April 12th 2024
A comprehensive investigation confirmed Ovaprene's non-hormonal design achieves consistent contraceptive efficacy, paving the way for further pivotal trials in pregnancy risk assessment.
23rd Annual International Congress on the Future of Breast Cancer® East
July 19-20, 2024
Register Now!
Expert Illustrations & Commentaries™: Targeting Immune Cells to Treat Multiple Sclerosis
View More
15th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™
May 11, 2024
View More
Community Practice Connections™: 14th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies
View More
4th Annual International Congress on the Future of Women’s Health™
View More
Patient, Provider, and Caregiver Connection™: Exploring Unmet Needs In Postpartum Depression – Making the Case for Early Detection and Novel Treatments
View More
Identifying Health Care Inequities in Screening, Diagnosis, and Trial Access for Breast Cancer Care: Taking Action With Evidence-Based Solutions
View More
ACOG recommends screening for ‘reproductive coercion’
February 14th 2013A new American College of Obstetricians and Gynecologists (ACOG) committee opinion (no. 554) addresses the detection and prevention of sexual coercion and violence within women’s relationships. The opinion was developed by the Committee on Health Care for Underserved Women.
Read More
The Leadership Report: The Best Ob/Gyn Research From 2012
February 14th 2013From ASRM’s removal of the ‘experimental’ label from the procedure of oocyte cryopreservation, to discoveries into the complex genetic processes involved in ovarian cancer, 2012 was another important year in ob/gyn research. Here, the leaders of seven major ob/gyn societies reflect on the most exciting research of the last year.
Read More
PCOS Increases Risk of Venous Thromboembolism for Women on Oral Contraceptives
December 26th 2012Women with polycystic ovary syndrome who take combined oral contraceptives are more than twice as likely as women without PCOS who take oral contraceptives to have a venous thromboembolism (VTE), according to the findings of a new study.
Read More
IUD May Effectively Treat Early-Stage Endometrial Cancer
November 12th 2012An intrauterine device (IUD) is an effective tool in the treatment of early-stage endometrial cancer in certain patients, according to the results of a small study presented at the International Gynecological Cancer Society’s 14th biennial meeting.
Read More
AAGL 2012: Poor Pregnancy Outcomes Confirm Need Contraceptive Counseling after Endometrial Ablation
November 9th 2012The use of NovaSure for endometrial ablation results a variety of poor pregnancy outcomes, according to a study presented by Shannon Smith, MD, at the Global Congress of the American Association of Gynecologic Laparoscopists.
Read More
Drospirenone-Containing Contraceptives Increase Risk of Thrombotic Events
November 5th 2012Compared with older low-dose combined hormonal contraceptives (CHCs), drospirenone-containing contraceptives are associated with a higher risk of thrombotic events, according to the results of a new FDA-funded study.
Read More
Controlling Pain During Tubal Sterilization Using Hysteroscopy
October 12th 2012According to the findings of a new intervention review and meta-analysis, neither paracervical block with lidocaine nor conscious sedation significantly reduced overall pain scores for tubal sterilization with hysteroscopy.
Read More
Most Progestin-Only Contraceptives Do Not Increase Venous Thromboembolism Risk
September 12th 2012Compared with women who do not use hormonal contraception, most women who take progestin-only contraception are not at increased risk for venous thromboembolism, according to the results of a new meta-analysis.
Read More
Combined Hormonal Birth Control: Fear-Promoting Headlines Just Hype
July 9th 2012In the largest study of its kind, researchers found increased risk for myocardial infarction and thrombotic stroke in women using combined estrogen-progestin contraceptives. However, news headlines tend to overstate the risk, and patients may have new concerns about the safety of their hormonal contraceptive.
Read More
IUDs Are Effective Emergency Contraception
May 18th 2012Typically used for long-term contraception, the intrauterine device (IUD) is also an effective emergency contraceptive if implanted after unprotected sex. Two IUDs, which are T-shaped pieces of plastic, are available in the United States.
Read More
ACOG: Providers Underestimate Pain Intensity During IUD Insertion
May 8th 2012Providers underestimate the intensity of patients’ pain during IUD insertion, and often misidentify the moment at which maximum pain occurs, according to a randomized trial of 200 women. Midlevel providers are slightly better at estimating pain intensity.
Read More
Ulipristal is Safe and Effective for Uterine Fibroids
February 10th 2012Ulipristal is a safe and effective option for women with uterine fibroids, according to two new studies published in the New England Journal of Medicine. In both studies, the oral selective progesterone receptor modulator was well-tolerated, rapidly reduced excessive bleeding, and decreased the size of uterine fibroids.
Read More
The Utility of Magnetic Resonance Imaging (MRI) and How It Is Used to Diagnose Uterine Fibroids
December 7th 2011William Parker, MD discusses the use of MRI in diagnosing and managing uterine fibroids. Dr. Parker's upcoming Clinical Opinion article, “The utility of MRI for the surgical treatment of women with uterine fibroid tumors”, will be published in the American Journal of Obstetrics and Gynecology in 2012.
Read More